Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-25

Clinical Trial Update: Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity [Phase 3]

View source ↗

Summary

Phase 3 trial comparing urinary hCG with recombinant hCG for achieving oocyte maturity in in vitro fertilization; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • recombinant hCG (human chorionic gonadotropin)
  • urinary hCG (human chorionic gonadotropin (hCG) derived from urine)

Snippet

Sponsor: Royan Institute | Conditions: In Vitro Fertilization | Phase 3 | Status: COMPLETED